Table 1 Baseline characteristics of patients

Age

63.4 ± 8.8

62.0 ± 10.8

0.656

Male

20 (66.7%)

8 (66.7%)

1.000

Height (cm)

161.8 ± 9.5

161.7 ± 8.2

0.958

Weight (kg)

65.8 ± 11.2

68.4 ± 14.0

0.523

Body mass index (kg/m²)

25.01 ± 2.90

25.99 ± 4.06

0.387

Smoker

10 (33.3%)

1 (8.3%)

0.247

Hypertension

23 (76.7%)

7 (58.3%)

0.274

Diabetes mellitus

9 (30.0%)

2 (16.7%)

0.464

Hyperlipidemia

28 (93.3%)

8 (66.7%)

0.046

Chronic kidney disease

3 (10.0%)

1 (8.3%)

1.000

Laboratory findings

  Hemoglobin (g/dL)

14.07 ± 1.78

13.58 ± 2.00

0.445

  Fasting blood glucose (mg/dL)

109.9 ± 27.7

99.0 ± 14.80

0.206

  HbA1c (%)

6.41 ± 0.82

5.97 ± 0.31

0.016

  Creatinine (mg/dL)

1.22 ± 0.22

1.21 ± 0.32

0.924

  Total cholesterol (mg/dL)

152.4 ± 29.7

175.4 ± 21.9

0.020

  Triglyceride (mg/dL)

115.3 ± 52.5

128.5 ± 107.7

0.595

  HDL cholesterol (mg/dL)

46.5 ± 10.7

50.4 ± 10.4

0.288

  LDL cholesterol (mg/dL)

88.4 ± 24.2

102.4 ± 20.3

0.084

  hsCRP (mg/dL)

0.240 ± 0.405

0.101 ± 0.101

0.270

  LVH by ECG criteria

5 (16.7%)

2 (16.7%)

1.000

Medications

  Aspirin

21 (95.5%)

13 (68.4%)

0.036

  Clopidogrel

17 (77.3%)

7 (36.8%)

0.012

  Calcium channel blockers

12 (54.5%)

6 (31.6%)

0.209

  ACEI

5 (22.7%)

4 (21.1%)

1.000

  Angiotensin receptor blockers

6 (27.3%)

6 (31.6%)

1.000

  Beta-blockers

13 (59.1%)

11 (57.9%)

1.000

  Diuretics

4 (18.2%)

3 (15.8%)

1.000

  Alpha-blockers

2 (9.1%)

3 (15.8%)

0.649

  Nitrate

7 (31.8)

4 (21.1%)

0.499

  Statins

20 (90.9%)

14 (73.7%)

0.219